Genapsys
Edit

Genapsys

http://www.genapsys.com/
Last activity: 09.09.2021
Active
Categories: FastHealthTechInformationLearnLEDMedTechPlatformProductResearchTechnology
GenapSys is developing a disruptive DNA-sequencing technology that enables fast, accurate, and ultra-low cost genetic testing. Although DNA Sequencing has led to rapid advancements in the field of medicine and healthcare, costs, turnaround times, and workflow inhibit mass use, especially in the clinical realm. The GenapSys sample-to-answer instrument provides a 100x solution – with orders of magnitude improvement across all dimensions of cost (including the cost of the instrument, cost per test, cost of labor, and cost of informatics), speed, and an automated sample-in data-out workflow. These orders of magnitude improvements will open up new markets and enable the democratization of sequencing on a mass scale.
Likes
112
Followers
7.92K
Mentions
30
Location: United States, California, Mountain View
Employees: 51-200
Phone: (650) 330-1096
Total raised: $280.5M
Founded date: 2010

Investors 3

Funding Rounds 5

DateSeriesAmountInvestors
27.05.2021Series D$70M-
07.02.2020-$75M-
21.11.2019Series C$90M-
15.11.2013Series B$37M-
22.03.2013-$8.5M-

Mentions in press and media 30

DateTitleDescription
09.09.2021Genapsys Adds to its Leadership Team with Two New HiresGenapsys, Inc. (Genapsys), a company developing a highly accurate and scalable electronic sequencing platform, announced the additions of Priya Ray and Peter Swider to the Company’s leadership team as well as the launch of the company’s new...
08.07.2021GenapSys Expands Executive and Leadership Teams with Key New Hires
24.06.2021GenapSys™ Announces Additions to the Company's Executive Team
01.06.2021Circle’s raise is the latest in the crypto cash rushGood morning, and hope you had a wonderful Memorial Day weekend. This is Fortune finance reporter Rey Mashayekhi, filling in for Lucinda while she takes a well-deserved break. Paid Content Change your marketer experience and unleash growth ...
01.06.2021Circle’s raise is the latest in the crypto cash rushThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Good morning, and hope you had a wonderful Memorial Day weekend. This is Fortune finance reporter...
27.05.2021Electronic Sequencing Platform GenapSys Raises $70 MillionGenapSys, a company developing a highly accurate and scalable electronic sequencing platform, announced it has raised $70 million in a Series D round. GenapSys — a company developing a highly accurate and scalable electronic sequencing plat...
27.05.2021GenapSys Receives $70M Series D Funding REDWOOD CITY, CA, GenapSys today announced it has raised $70 million in a Series D equity financing. >> Click here for more funding data on GenapSys >> To export GenapSys funding data to PDF and Excel, click here GenapSys...
27.05.2021GenapSys Raises $70M in Series D Equity FinancingGenapSys, a Redwood City, CA-based company developing a scalable electronic sequencing platform, raised $70m in Series D equity financing. Backers included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM Capital, an...
27.05.2021GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of Directors
27.05.2021GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of DirectorsREDWOOD CITY, Calif., May 27, 2021 /PRNewswire/ -- GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Inve...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In